These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31123412)

  • 1. Investigation of the prevalence of genes conferring resistance to carbapenems in
    Khosravi AD; Taee S; Dezfuli AA; Meghdadi H; Shafie F
    Infect Drug Resist; 2019; 12():1153-1159. PubMed ID: 31123412
    [No Abstract]   [Full Text] [Related]  

  • 2. High Rates of Aminoglycoside Methyltransferases Associated with Metallo-Beta-Lactamases in Multidrug-Resistant and Extensively Drug-Resistant
    El-Far A; Samir S; El-Gebaly E; Omar M; Dahroug H; El-Shenawy A; Soliman NS; Gamal D
    Infect Drug Resist; 2021; 14():4849-4858. PubMed ID: 34848977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
    Sarı B; Baran I; Alaçam S; Mumcuoğlu İ; Kurşun Ş; Aksu N
    Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of carbapenemase genes among multidrug-resistant
    Saengsuwan P; Kositpantawong N; Kawila S; Patugkaro W; Romyasamit C
    Saudi Med J; 2022 Sep; 43(9):991-999. PubMed ID: 36104060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
    J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Molecular Characterization of Carbapenemase Genes in Association with Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from Tertiary Healthcare Facilities in Southwest Nigeria.
    Olaniran OB; Adeleke OE; Donia A; Shahid R; Bokhari H
    Curr Microbiol; 2021 Dec; 79(1):27. PubMed ID: 34905085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Carbapenemase Encoding Gene and Resistance to Cefiderocol in Hospital and Community eXtensive Drug Resistance and Carbapenem-Resistant
    Benzaarate I; El Otmani F; Khazaz A; Timinouni M; Bourjilat F; Bogaerts P; Huang TD; Nayme K
    Foodborne Pathog Dis; 2023 Oct; 20(10):460-466. PubMed ID: 37616567
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant
    Hosseininassab Nodoushan SA; Yadegari S; Moghim S; Isfahani BN; Fazeli H; Poursina F; Nasirmoghadas P; Safaei HG
    Adv Biomed Res; 2017; 6():74. PubMed ID: 28706882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary.
    O'Neall D; Juhász E; Tóth Á; Urbán E; Szabó J; Melegh S; Katona K; Kristóf K
    Acta Microbiol Immunol Hung; 2020 Mar; 67(1):61-65. PubMed ID: 32208923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallo-β-lactamase-mediated resistance among clinical carbapenem-resistant
    Dogonchi AA; Ghaemi EA; Ardebili A; Yazdansetad S; Pournajaf A
    Ci Ji Yi Xue Za Zhi; 2018; 30(2):90-96. PubMed ID: 29875589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
    Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
    Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-Resistance Genes in Pseudomonas aeruginosa from Wound Infections in a Tertiary Health Institution in Osogbo, Nigeria.
    Akinloye AO; Adefioye JO; Adekunle CO; Anomneze BU; Makanjuola OB; Onaolapo OJ; Onaolapo AY; Olowe OA
    Infect Disord Drug Targets; 2021; 21(1):90-98. PubMed ID: 31957616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Carbapenem-Resistant
    Radan M; Moniri R; Khorshidi A; Gilasi H; Norouzi Z; Beigi F; Dasteh Goli Y
    Arch Trauma Res; 2016 Sep; 5(3):e33664. PubMed ID: 27800466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
    Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
    PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021.
    Lee YL; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2023 Aug; 62(2):106867. PubMed ID: 37244423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of bla
    Bazgir ZN; Ahanjan M; Goli HR; Gholami M; Ghasemian R; Hashemi-Soteh MB
    Recent Adv Antiinfect Drug Discov; 2021; 16(2):148-156. PubMed ID: 34961433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.